Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01412333 |
|---|---|
| Brief Title: | A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis |
| First Submitted : | August 8, 2011 |
| First Submitted that Met QC Criteria : | August 8, 2011 |
| First Posted : | August 9, 2011 (Estimate) |
| Results First Submitted : | March 30, 2017 |
| Results First Submitted that Met QC Criteria : | July 17, 2017 |
| Results First Posted : | July 18, 2017 |
| Certification/Extension First Submitted : | October 21, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | October 25, 2016 |
| Certification/Extension First Posted : | October 26, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 7, 2024 |
| Last Update Posted : | March 8, 2024 |